Fosun Pharma proposes share option scheme for employees

Shanghai Fosun Pharmaceutical announced a proposed share option scheme for employees, pending shareholder approval.

The company will grant a maximum of 5,726,100 share options, representing 0.2144% of total shares. The first grant comprises 4,580,900 options with an exercise price of RMB27.93 per share, based on average trading price preceding the announcement.

Performance targets for exercise include net profit attributable to the parent and revenue from innovative drugs.